WeVote

Bill

Bill

H 2447

An Act authorizing a 90-day supply of medically necessary testosterone therapy medication

194th Legislature (2025-2026) Introduced by Jamie Eldridge and 2 co-sponsors

H 2447 permits Massachusetts patients to obtain 90-day supplies of prescribed testosterone therapy instead of 30-day quantities to improve medication continuity and treatment adherence.

Committee recommended bill ought to pass and referred to the committee on House Ways and Means
0
WeVote Research Nonpartisan
Bill Summary · H 2447

Legislative bill overview

H 2447 authorizes patients to receive a 90-day supply of medically necessary testosterone therapy medication rather than the standard 30-day prescription limit. The bill aims to improve access and continuity of care for patients requiring testosterone replacement therapy by allowing larger quantity dispensing in a single prescription.

Why is this important

Testosterone therapy requires consistent, uninterrupted dosing for medical effectiveness and patient safety. Allowing 90-day supplies reduces the frequency of pharmacy visits and prescription refills, which can improve medication adherence and reduce gaps in treatment. This is particularly relevant for patients with limited transportation, time, or pharmacy access.

Potential points of contention

  • Insurance and cost implications: Insurers may resist larger dispensing amounts, and questions remain about whether 90-day supplies will increase out-of-pocket costs for patients in single transactions despite potential long-term savings
  • Pharmacy logistics and storage: Pharmacies may face inventory management challenges, and patients need adequate storage conditions for testosterone medications (which vary by formulation—injectables, gels, patches have different stability requirements)
  • Medical oversight concerns: Some healthcare providers may argue that shorter prescription cycles allow for better monitoring of side effects and dosage adjustments, particularly for patients new to therapy

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.